NASDAQ:VLON
Delisted

Vallon Pharmaceuticals Stock Signals

etoro logo Buy VLON
*Your capital is at risk
$0.400
+0 (+0%)
At Close: Jul 20, 2023

Latest Data & Signals Issued

Below are some of the latest signals issued for Vallon Pharmaceuticals, Inc.

General

Signal Type Signal Value Data
Score 0.000 60 days ( 0 %
Last Price $0.400 0 %
Performance History
7 Days
$0.400 $0.400
0%
30 Days
$0.400 $0.400
0%
12 Mos
$0.512 $0.400
-21.83%

6/18

Active Buy Signals

Specific Signals

Short Term
Net score: 30.41
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.400 - $0.400
Trend - 3 mos 0 % High Width: 0.00000000000019 %
Pred. range - 3 mos $0.400 - $0.400 Low 0 % - 0 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Jul 19, 2023 - 2 days
RSI Short Pivot Signal Buy Very Low May 05, 2023 - 52 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Apr 28, 2023 - 57 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 37.01
Signal Type Signal Value Importance Data
Trend - 12 mos 8.29 % Very High Width: 1,221.88 %
Pred. range - 12 mos $0.0746 - $0.99 High -81.36 % - 146.39 %
Short MA 12 mos Sell Very High Apr 20, 2023 - 63 days
Long MA 12 mos Sell Very High May 18, 2023 - 43 days
Short/Long MA 12 mos Sell Very High May 18, 2023 - 43 days
Pivot Long Buy Low Apr 21, 2023 - 62 days
RSI Long Pivot Signal Buy Low May 16, 2023 - 45 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT VALLON PHARMACEUTICALS, INC.
Vallon Pharmaceuticals
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medications for central nervous system disorders with a focus on abuse-deterrent medications. Its lead investigational product candidate is ADAIR, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder (ADHD) and narcolepsy. The company is also develo...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE